Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Advanced Course on EGFR-Mutated NSCLC 2021

21 - 23 Jun 2021


Slides and webcasts from all ESMO Advanced courses are open to all, ESMO Members and free ESMO Account holders, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The use of these presentations is for personal educational purposes only.

Learning objectives

  • Understanding the biology of EGFR in normal and malignant cells
  • Gaining insights in the spectrum of EGFR activating mutations, platforms, and strategies for molecular testing
  • Understanding the role of biomarkers in selecting NSCLC patients for EGFR TKIs
  • Discussing state-of-the-art therapeutic strategies and clinical research in EGFR mutated NSCLC
  • Managing toxicity and how to use EGFR TKIs in specific subgroups of patients

This event has been supported by an unrestricted educational grant from AstraZeneca.

Filter by:

There are 17 resources available

Welcome and introduction

Presenter: P. A. Jänne, US, T. S. K. Mok, HK, S. Peters, CH

Session: Welcome and introduction




This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.